Effect of EGFR-inhibition on the radiation response of oral mucosa: Experimental studies in mouse tongue epithelium

International Journal of Radiation Biology

Volumn 81, Issue 6, 2005, Pages 437-443

  Fehrmann, A ^a,c   Dorr W ^a,b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Epidermal growth factor receptor; Fractionated irradiation; Oral mucositis; Tyrosin kinase inhibition

Indexed keywords

BIBX 1382BS; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; MALE; MOUSE; MOUTH MUCOSA; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; TISSUE REGENERATION; TONGUE;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, RADIATION; MICE; MICE, INBRED C3H; MOUTH MUCOSA; RADIATION TOLERANCE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TONGUE;

ANIMALIA;

EID: 27844602228     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000500168515     Document Type: Article

References (31)

1. Baumann M, Krause M, Zips D, Eicheler W, Dörfler A, Ahrens J, Petersen C, Brüchner K, Hilberg F. 2003. Selective inhibition of the epidermal growth factor receptor tyrosine kinase by BIBX1382BS and the improvement of growth delay, but not local control, after fractionated irradiation in human FaDu squamous cell carcinoma in the nude mouse. International Journal of Radiation Biology 79:547-559.
2. Bentzen SM, Saunders MI, Dische S, Bond SJ. 2001. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiotherapy and Oncology 60:123-135.
3. Bonner JA, Raisch KP, Trummell HQ, Robert F, Meredith RF, Spencer SA, Buchsbaum DJ, Saleh MN, Stackhouse MA, Lobuglo AF, Peters GE, Carroll WR, Warsal HW. 2000. Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancer. Journal of Clinical Oncology 18:47S-53S.
4. Caponigro F. 2004. Rationale and clinical validation of epidermal growth factor receptor as a target in the treatment of head and neck cancer. Anticancer Drugs 15:311-320.
5. Cohen BD, Green JM, Foy L, Fell HP. 1996. HER4-mediated biological and biochemical properties in NIH 3T3 cells. Evidence for HER1-HER4 heterodimers. Journal of Biological Chemistry 271:4813-4818.
6. Denham JW, Walker QJ, Lamb DS, Hamilton CS, O'Brien PC, Spry NA, Hindley A, Poulsen M, O'Brien M, Tripcony L. 1996. Mucosal regeneration during radiotherapy. Transactions of the Tasman Radiation Oncology Group (TROG). Radiotherapy and Oncology 41:109-118.
7. Dörr W. 1997. Three A's of repopulation during fractionated irradiation of squamous epithelia: asymmetry loss, acceleration of stem-cell divisions and abortive divisions. International Journal of Radiation Biology 72:635-643.
8. Dörr W. 2000. Radiation-induced changes in expression of EGF and EGF-R in mouse tongue epithelium. Molecular Radiation Biology/Oncology 1:57(abst).
9. Dörr W. 2003. Modulation of repopulation processes in oral mucosa: experimental results. International Journal of Radiation Biology 79:531-537.
10. Dörr W, Brankovic K, Hartmann B. 2000. Repopulation in mouse oral mucosa: changes in the effect of dose fractionation. International Journal of Radiation Biology 76:383-390.
11. Dörr W, Emmendörfer H, Haide E, Kummermehr J. 1994. Proliferation equivalent of 'accelerated repopulation' in mouse oral mucosa. International Journal of Radiation Biology 66:157-167.
12. Dörr W, Hamilton CS, Boyd T, Reed B, Denham JW. 2002a. Radiation-induced changes in cellularity and proliferation in human oral mucosa. International Journal of Radiation Oncology Biology Physics 52:911-917.
13. Dörr W, Kummermehr J. 1990. Accelerated repopulation of mouse tongue epithelium during fractionated irradiations or following single doses. Radiotherapy and Oncology 17:249-259.
14. Dörr W, Noack R, Spekl K, Farrell CL. 2001. Modification of oral mucositis by keratinocyte growth factor: single radiation exposure. International Journal of Radiation Biology 77:341-347.
15. Dörr W, Spekl K, Farrell CL. 2002b. Amelioration of acute oral mucositis by keratinocyte growth factor: fractionated irradiation. International Journal of Radiation Oncology Biology Physics 54:245-251.
16. Egeblad M, Mortensen OH, van Kempen LC, Jaattela M. 2001. BIBX1382BS, but not AG1478 or PD153035, inhibits the ErbB kinases at different concentrations in intact cells. Biochemical and Biophysical Research Communications 281:25-31.
17. Fletcher GH, Maccomb WS, Shalek RJ. 1962. Radiation therapy in the management of the cancer of the oral cavity and oropharynx (Springfield : Charles Thomas).
18. Harari PM, Huang SM. 2001. Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation. International Journal of Radiation Oncology Biology Physics 49:427-433.
19. Kaanders JHAM, Pop LAM, Marres HAM, Bruaset I, van den Hoogen FJ, Merkx MA, van der Kogel AJ. 2002. ARGON. Experience in 215 patients with advanced head-and-neck cancer. International Journal of Radiation Oncology Biology Physics 52:769-778.
20. Kase M. 2001. Immunohistochemical studies on the expression of EGF and EGFR in irradiated mouse oral mucosa treated with KGF. Project Report, MSc Radiobiology Course, University College of London.
21. Maciejewski B, Zajusz A, Pilecki B, Swiatnicka J, Skladowski K, Dörr W, Kummermehr J, Trott KR. 1991. Acute mucositis in the stimulated oral mucosa of patients during radiotherapy for head and neck cancer. Radiotherapy and Oncology 22:7-11.
22. Milas L, Mason K, Hunter N, Petersen S, Yamakawa M, Ang KK, Mendelsohn J, Fan Z. 2000. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. Clinical Cancer Research 6:701-708.
23. Nuijen B, Bouma M, Henrar RE, Brauns U, Bette P, Bult A, Beijnen JH. 2000. In vitro biocompatibility studies with the experimental anticancer agent BIBX1382BS. International Journal of Pharmacology 194:261-267.
24. Pabst S, Spekl K, Dörr W. 2004. Changes in the effect of dose fractionation during daily fractionated irradiation: studies in mouse oral mucosa. International Journal of Radiation Oncology Biology Physics 58:485-492.
25. erbB4, a fourth member of the Epidermal Growth Factor Receptor family. Proceedings of the National Academy of Sciences, USA 90:1746-1750.
26. SAS Institute, Inc. 1990. SAS/STAT User's guide version 6. Gary, NC: SAS Institute.
27. Schmidt-Ullrich RK, Mikkelsen RB, Dent P, Todd DG, Valerie K, Kavanagh BD, Contessa JN, Rorrer WK, Chen PB. 1997. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene 15:1191-1197.
28. Schmidt-Ullrich RK, Valerie K, Fogleman PB, Walters J. 1996. Radiation-induced autophosphorylation of epidermal growth factor receptor in human malignant mammary and squamous epithelial cells. Radiation Research 145:81-85.
29. Sepp-Lorenzino L, Eberhard I, Ma Z, Cho C, Serve H, Liu F, Rosen N, Lupu R. 1996. Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells. Oncogene 12:1679-1987.
30. Srinivasan R, Poulsom R, Hurst HC, Gullick WJ. 1998. Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. Journal of Pathology 185:236-245.
31. Trotti A. 2000. Toxicity in head and neck cancer: a review of trends and issues. International Journal of Radiation Oncology Biology Physics 47:1-12.